CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...

Please provide your email address to receive an email when new articles are posted on . AliveCor announced its next-generation AI algorithms for ECG interpretation have received 510(k) clearance from ...

A new clinical study shows that PulseAI’s deep learning AI demonstrates superiority over the Apple Watch ECG in the detection of atrial fibrillation. Results have been accepted for presentation at the ...

Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden death in adolescents and initial detection is often difficult. A new UCSF study finds that Artificial Intelligence-enhanced ...

Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...

Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...

San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...

Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive ...

The latest beta of Apple Watch watchOS 7.2 has added a new version of Apple's ECG monitoring system's algorithm, seemingly the first revision since the original. Within the latest beta of forthcoming ...

Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...